Steven Cohen Cerus Corp Transaction History

Point72 Asset Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $1.7 Million - $2.75 Million	-948,903 Reduced 89.49%	111,400 $274,000
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $2.81 Million - $4.04 Million	1,060,303 New	1,060,303 $3.15 Million
Q3 2020 Nov 16, 2020	SELL	$5.78 - $7.47 $2.17 Million - $2.8 Million	-375,034 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.5 - $7.02 $950,553 - $1.48 Million	211,234 Added 128.96%	375,034 $2.48 Million
Q1 2020 May 15, 2020	SELL	$2.87 - $5.49 $899,524 - $1.72 Million	-313,423 Reduced 65.68%	163,800 $762,000

Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $1.3 Million - $1.91 Million	-288,981 Reduced 37.72%	477,223 $2.68 Million
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $3.95 Million - $5.25 Million	766,204 New	766,204 $4.77 Million

152

144M

39.6K

60.9K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.